NeuroKaire logo

NeuroKaire

Develops blood-based tools for antidepressant selection and precision psychiatry.

ShareLink copied

The record

Headquarters
Kearny, New Jersey, United States, and Tel Aviv, Israel
Region
North America
Vertical
Mental & Behavioural Health
Sub-segment
Precision psychiatry diagnostics
Product type
Diagnostics
Stage
Series A
Founded
2018

What they do

BrightKaire uses a blood draw at Quest labs or a provider office to generate patient-specific neurons. An algorithm ranks antidepressants by their effects on those neurons, and results are delivered through a provider portal. NeuroKaire reports AUC 0.81 and 84% positive predictive value. The December 2024 release says the test includes pharmacogenetic screening covering 132 drugs. The company also supports pharmaceutical and biotechnology drug development in psychiatry and neurology.

Leadership & founders

Investors

  • GreyBird Ventures
  • Meron Capital
  • Jumpspeed Ventures
  • Sapir Venture Partners

History and progression

How NeuroKaire got here, step by step.

  1. 2018

    Founded as Genetika+

    Talia Cohen Solal and Daphna Laifenfeld founded Genetika+.

  2. 30 September 2021

    $10 million Series A

    GreyBird Ventures led the round with Meron Capital, Jumpspeed Ventures, Sapir Venture Partners, Howard Morgan and Michael Zeisser, to fund trials and a clinical lab in Boston.

  3. 17 December 2024

    $10 million to scale

    GreyBird Ventures led funding with Meron Capital and Jumpspeed Ventures to scale operations and pharmaceutical partnerships.

  4. 15 November 2026

    BrightKaire at HLTH

    NeuroKaire showcased BrightKaire at HLTH 2026 in Las Vegas.

Key products

BrightKaire
A blood draw at Quest labs or a provider office generates patient-specific neurons. An algorithm ranks antidepressants by their effect on those neurons, with results in a provider portal. The company reports AUC 0.81 and 84% positive predictive value.
Pharma and biotech services
Precision medicine support for drug development in psychiatry and neurology.

Recent news

  1. 15 November 2026

    NeuroKaire showcases BrightKaire at HLTH

Is this your company? Get a Verified profile